Cite

HARVARD Citation

    Parra-Izquierdo, I. et al. (2022). Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function. Platelets. pp. 404-415. [Online]. 
  
Back to record